Pharming Group N.V.
PHAR
$7.65
-$0.675-8.11%
| 06/30/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | ||
|---|---|---|---|---|---|
| Net Income | -- | -10.55M | -22.06M | -16.42M | |
| Total Depreciation and Amortization | -- | 10.13M | 10.25M | 9.30M | |
| Total Amortization of Deferred Charges | -- | 884.00K | 720.00K | 720.00K | |
| Total Other Non-Cash Items | -- | -802.00K | -1.19M | -3.75M | |
| Change in Net Operating Assets | -- | -16.96M | -11.36M | -4.40M | |
| Cash from Operations | -- | -17.30M | -23.64M | -14.56M | |
| Capital Expenditure | -- | -1.44M | -1.44M | -1.63M | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -127.95M | -124.44M | -66.32M | |
| Cash from Investing | -- | -129.39M | -125.88M | -67.95M | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -4.86M | -4.50M | -4.29M | |
| Issuance of Common Stock | -- | 9.49M | 10.40M | 2.67M | |
| Repurchase of Common Stock | -- | -695.00K | -695.00K | -695.00K | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -4.98M | -4.94M | -4.59M | |
| Cash from Financing | -- | -1.04M | 259.00K | -6.90M | |
| Foreign Exchange rate Adjustments | -- | 2.13M | 15.21M | 4.47M | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -- | -145.60M | -134.05M | -84.94M | |
